compound 30 [PMID: 37057760]   Click here for help

GtoPdb Ligand ID: 12609

Compound class: Synthetic organic
Comment: This compound is a dual inhibitor of Janus kinase 2 (JAK2) and histone deacetylases (HDACs) [1]. Based on in vitro and in vivo activities it is proposed for treatment of haematologic and solid cancers. JAK2 inhibition is achieved through its fedratinib-based moiety.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 5
Rotatable bonds 16
Topological polar surface area 161.89
Molecular weight 588.7
XLogP 1.75
No. Lipinski's rules broken 2
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=C(NC2=CC=CC(=C2)S(=O)(=O)NC(C)(C)C)N=C(N=C1)NC3=CC=C(C(=C3)F)OCCCCCCC(=O)NO
Isomeric SMILES CC(C)(NS(C1=CC(NC2=NC(NC3=CC=C(OCCCCCCC(NO)=O)C(F)=C3)=NC=C2C)=CC=C1)(=O)=O)C
InChI InChI=1S/C28H37FN6O5S/c1-19-18-30-27(33-26(19)31-20-10-9-11-22(16-20)41(38,39)35-28(2,3)4)32-21-13-14-24(23(29)17-21)40-15-8-6-5-7-12-25(36)34-37/h9-11,13-14,16-18,35,37H,5-8,12,15H2,1-4H3,(H,34,36)(H2,30,31,32,33)
InChI Key XQYXAGOVMRYFIS-UHFFFAOYSA-N
References
1. Qiu Q, Chi F, Zhou D, Xie Z, Liu Y, Wu H, Yin Z, Shi W, Qian H. (2023)
Exploration of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Bispecific Inhibitors Based on the Moiety of Fedratinib for Treatment of Both Hematologic Malignancies and Solid Cancers.
J Med Chem, 66 (8): 5753-5773. [PMID:37057760]